1 year return (CAGR)
166.88%
Abcellera Biologics Inc Exchange (NASDAQ, USD)
ABCL
12.73
+1.06 (+9.08%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
35.30%
5 year return (CAGR)
-7.13%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.13B
Price/Sales
62.34
Ent value
4.42B
Price/Book
4.60
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.15 |
| Daily high | 13.18 |
| Daily low | 11.99 |
| Daily Volume | 8.02M |
| All-time high | 53.20 |
| 1y analyst estimate | 17.13 |
| Beta | 1.19 |
| EPS (TTM) | -0.54 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 24 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ABCL | S&P500 | |
| Current price drop from All-time high | -76.07% | -1.96% |
| Highest price drop | -96.37% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -81.81% | -10.68% |
| Avg time to new high | 241 days | 12 days |
| Max time to new high | 1414 days | 1805 days |
News
